Long-Term Impact of D2 Lymphadenectomy during Gastrectomy for Cancer: Individual Patient Data Meta-Analysis and Restricted Mean Survival Time Estimation
Cancers · 19.01.2024 · 16 (2) · 424
DOI: 10.3390/cancers16020424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 19.01.2024. Verfasst von Alberto Aiolfi und 12 weiteren Autor:innen. Beteiligte Einrichtung: I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Via C. Bel…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Debate exists concerning the impact of D2 vs. D1 lymphadenectomy on long-term oncological outcomes after gastrectomy for cancer.
Methods
PubMed, MEDLINE, Scopus, and Web of Science were searched and randomized controlled trials (RCTs) analyzing the effect of D2 vs. D1 on survival were included. Overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS) were assessed. Restricted mean survival time difference (RMSTD) and 95% confidence intervals (CI) were used as effect size measures.
Results
Five RCTs (1653 patients) were included. Overall, 805 (48.7%) underwent D2 lymphadenectomy. The RMSTD OS analysis shows that at 60-month follow-up, D2 patients lived 1.8 months (95% CI −4.2, 0.7; p = 0.14) longer on average compared to D1 patients. Similarly, 60-month CSS (1.2 months, 95% CI −3.9, 5.7; p = 0.72) and DFS (0.8 months, 95% CI −1.7, 3.4; p = 0.53) tended to be improved for D2 vs. D1 lymphadenectomy.
Conclusions
Compared to D1, D2 lymphadenectomy is associated with a clinical trend toward improved OS, CSS, and DFS at 60-month follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Via C. Belgioioso, 173, 20157 Milan, Italy.
- Surgery Clinic 3, Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", "Iuliu Hațieganul" University of Medicine and Pharmacy, 400394 Cluj-Napoca, Romania.
- I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio, Division of General Surgery, Department of Surgery, University of Insubria, 20157 Milan, Italy.
- Department of General Surgery and Medical Surgical Specialties, G. Rodolico Hospital, Surgical Division, University of Catania, 95131 Catania, Italy.
- Department of Biomedical Sciences for Health, Division of General and Foregut Surgery, IRCCS Policlinico San Donato, University of Milan, 20097 Milan, Italy.
ORCID-Profile: Alberto Aiolfi, Diana Schlanger, Antonio Biondi, Luigi Bonavina
Zitieren
APA
Aiolfi, A., Bona, D., Bonitta, G., Lombardo, F., Manara, M., Sozzi, A., Schlanger, D., Popa, C., Cavalli, M., Campanelli, G., Biondi, A., Bonavina, L., & OGSA Group for Esophagogastric Surgery (2024). Long-Term Impact of D2 Lymphadenectomy during Gastrectomy for Cancer: Individual Patient Data Meta-Analysis and Restricted Mean Survival Time Estimation. Cancers, 16(2), 424. https://doi.org/10.3390/cancers16020424
Vancouver
Aiolfi A, Bona D, Bonitta G, Lombardo F, Manara M, Sozzi A, et al. Long-Term Impact of D2 Lymphadenectomy during Gastrectomy for Cancer: Individual Patient Data Meta-Analysis and Restricted Mean Survival Time Estimation. Cancers. 2024;16(2):424. doi:10.3390/cancers16020424
BibTeX
@article{Aiolfi2024,
author = {Aiolfi, Alberto and Bona, Davide and Bonitta, Gianluca and Lombardo, Francesca and Manara, Michele and Sozzi, Andrea and Schlanger, Diana and Popa, Calin and Cavalli, Marta and Campanelli, Giampiero and Biondi, Antonio and Bonavina, Luigi and OGSA Group for Esophagogastric Surgery, OGSA Group for Esophagogastric Surgery},
title = {Long-Term Impact of D2 Lymphadenectomy during Gastrectomy for Cancer: Individual Patient Data Meta-Analysis and Restricted Mean Survival Time Estimation},
journal = {Cancers},
year = {2024},
volume = {16},
number = {2},
pages = {424},
doi = {10.3390/cancers16020424}
}
EUVIMED